Attaining sustainability in inflammatory bowel disease

• by Olga Maria Nardone, Beatriz Gros, Tommaso Lorenzo Parigi, Aimen Farooq, Lumir Kunovsky, Shaji Sebastian

• November 19, 2025

Evaluation of 5-Aminosalicylic Acid Utilization in Crohn’s Disease Management: Insights from a Nationwide Survey of Inflammatory Bowel Disease Specialists

• by Yuanli Li, Changxin Chen, Chengdang Wang

• April 27, 2026

The role of a multidisciplinary approach in the early and differential diagnosis of inflammatory bowel disease–related spondyloarthritis: insights from a cross-sectional study

• by Alberto Floris, Leonardo Sichi, Agnese Favale, Marcella Falconi, Andrea Pace, Maria Maddalena Angioni, Angelo Italia, Raffaela Piras, Federica Olla, Francesca Onnis, Matteo Piga, Massimo Claudio Fantini, Sara Onali, Alberto Cauli

• May 12, 2026

Combo Therapy for Psoriasis With Obesity

A phase 3b trial tests ixekizumab plus tirzepatide in adults with moderate-to-severe plaque psoriasis and obesity or overweight.

• by Kathryn Wighton

• February 18, 2026

• 3 min